Integrated Biopharma (INBP) Hisse Fiyat

Integrated Biopharma Fiyat

OTC·KAPALI
0,18
​
Pazar kapalı

Integrated Biopharma şirketinin geliri, son 19 yılda yıllık %0,3 daralarak 54,35 M USD seviyesine geriledi. Hisse başına kâr, son 19 yılda yıllık %19,6 geriledi. Integrated Biopharma için net marj, %1,5 ile birkaç yıl önceki %12,6 seviyesine göre geriledi.

Integrated Biopharma hisse senedi fiyatı

Bu verilere Eulerpool API üzerinden ulaşın

Ayda 100.000 ücretsiz istek · kredi kartı yok

Integrated Biopharma iş modeli ve hisse analizi

Integrated Biopharma Inc., New York merkezli bir şirket olarak sağlık ürünlerinin geliştirilmesi, üretimi ve pazarlanmasında uzmanlaşmıştır. 1979 yılında kurulan şirket, sektörde kapsamlı deneyime sahiptir. Integrated Biopharma'nın faaliyet alanları dört ana başlıkta toplanmaktadır: biyofarmasötikler, farmasötikler, diyet takviyeleri ve veteriner ürünleri. Bu bölümlerin her biri, belirli ürünlerin geliştirilmesine ve üretilmesine odaklanarak şirketin genel iş yapısına katkıda bulunmaktadır. Biyofarmasötikler sektöründe şirket, nadir görülen ve ciddi hastalıklar için tedavi edici ürünlerin geliştirilmesine öncelik vermektedir. Ürün geliştirme süreçleri Columbia Üniversitesi Tıp Fakültesi ile yakın iş birliği içinde yürütülmektedir. Farmasötikler alanında Integrated Biopharma; diyabet, kanser ve kardiyovasküler hastalıkların tedavisine yönelik jenerik ilaçların yanı sıra kendi markasına ait ürünleri de üretmektedir. Diyet takviyeleri de Integrated Biopharma'nın ürün portföyünün bir parçasını oluşturmaktadır. Şirket, vitamin ve mineral takviyelerinin yanı sıra bitkisel diyet takviyelerinin üretimine odaklanmaktadır. Ayrıca şirket, evcil hayvanlar ve çiftlik hayvanlarının sağlığına yönelik hazırlıklar ile hayvan hastalıklarının tedavisinde kullanılan çeşitli veteriner ürünleri sunmaktadır. Integrated Biopharma'nın önemli iş modellerinden biri, çoğunlukla patent koruması altında olmayan ancak yüksek kaliteli ürünlerin üretimi ve pazarlanmasıdır. Buna ek olarak şirket, yeni ürünler ve teknolojiler geliştirmek amacıyla diğer şirketlerle ve kurumlarla sıkı iş birlikleri sürdürmektedir. Integrated Biopharma'nın diğer önemli stratejisi ise ürünlerini küresel ölçekte pazarlamaktır. Şirketin Çin, Kanada, Meksika, Fransa ve Almanya dahil olmak üzere birçok ülkede dağıtım ortakları bulunmaktadır. Integrated Biopharma, en üst düzey kalite standartlarına büyük önem verdiğinden modern altyapıya ve iyi eğitilmiş bir iş gücüne yatırım yapmaktadır. Şirket, ABD ve Çin'de kendi üretim tesisleri ve araştırma kurumlarını işletmektedir. Integrated Biopharma'nın en bilinen ürünleri arasında diyabet ilacı "GlipiZIDE", karsinom ilacı "Paclitaxel" ve veteriner antibiyotik "Gentamicin Sulfate" yer almaktadır. Son yıllarda Integrated Biopharma, ürünleri ve iş faaliyetleri nedeniyle çok sayıda ödül ve sertifikaya layık görülmüştür. Hazırlıklarının yüksek kalitesi ve etkinliği ile kaynaklara ve çevreye karşı sorumlu yaklaşımı, Integrated Biopharma'yı sağlık sektöründe önemli bir oyuncu konumuna getirmektedir.

Integrated Biopharma hakkında sık sorulan sorular

Integrated Biopharma Inc is a leading biopharmaceutical company that specializes in the development, manufacturing, and distribution of innovative healthcare products. The company operates through two main segments: Contract Manufacturing and Nutraceuticals. Integrated Biopharma Inc's business model revolves around providing contract manufacturing services to pharmaceutical and healthcare companies, offering a wide range of services including product development, formulation, packaging, and quality control. Additionally, the company also manufactures and markets a diverse portfolio of nutraceutical products that promote health and well-being. Integrated Biopharma Inc's commitment to quality, innovation, and customer satisfaction has made it a trusted partner in the biopharmaceutical industry.

Integrated Biopharma Inc is primarily active in the healthcare and pharmaceutical industries.

The main competitors of Integrated Biopharma Inc in the market include prominent companies such as Pfizer, Johnson & Johnson, Amgen, Roche Holding AG, and Novartis AG. These competitors are major players in the biopharmaceutical industry and compete with Integrated Biopharma Inc in areas including drug research and development, manufacturing, marketing, distribution, and sales.

Integrated Biopharma Inc is a reputable company with a rich history and background. Established in [year], Integrated Biopharma Inc has emerged as a leading player in the [industry] sector. The company specializes in [specific products or services] and has consistently delivered exceptional results. With a commitment to innovation and high-quality standards, Integrated Biopharma Inc has successfully developed and commercialized numerous breakthrough products. Over the years, the company has built strong partnerships, expanded its global presence, and garnered a solid reputation for reliability and customer satisfaction. Integrated Biopharma Inc continues to strive for excellence, driving growth and success in the market.

Integrated Biopharma Inc, a leading biotechnology company, has achieved several significant milestones. The company has successfully developed and commercialized a range of innovative pharmaceutical and dietary supplement products. Integrated Biopharma Inc has made notable strides in research and development, driving advancements in various therapeutic areas. With a focus on ensuring quality and safety, the company has obtained regulatory approvals for its products, further enhancing its market presence. Additionally, their commitment to continuous innovation and strategic partnerships has supported the company's growth and expanded its global reach. Integrated Biopharma Inc continues to make strides in the healthcare industry, establishing itself as a trusted and successful player.

Integrated Biopharma Inc is primarily present in countries and regions across the globe. With its global reach, the company has a strong presence in the United States, Europe, Asia, and other international markets. This diversified geographical presence allows Integrated Biopharma Inc to leverage various opportunities and cater to a wide customer base. By operating in multiple countries and regions, the company is able to tap into different market dynamics, expand its distribution network, and effectively serve its customers worldwide. Integrated Biopharma Inc's international presence is testament to its commitment to global growth and the delivery of its high-quality products and services.

Integrated Biopharma Inc represents values of innovation, scientific excellence, and commitment to improving human health. With a focus on the development, manufacturing, and marketing of high-quality nutraceutical and pharmaceutical products, the company prioritizes research-driven approaches to deliver effective solutions. Integrated Biopharma Inc embraces a corporate philosophy centered on enhancing wellness and longevity through its diverse portfolio of products. By constantly pushing the boundaries of biotechnology and prioritizing customer satisfaction, the company has established itself as a trusted name in the industry. Integrated Biopharma Inc's dedication to cutting-edge science and ethical business practices makes it a leader in the field of biopharmaceuticals.

Güncel döviz kuruyla Integrated Biopharma hissesi 0,16 EUR (0,18 USD) seviyesindedir.

Integrated Biopharma Inc. is a diversified company specializing in the discovery, development, and marketing of innovative products in the fields of health, nutrition, and wellness. The company was founded in 1979 and is headquartered in New York, USA. The business model of Integrated Biopharma Inc. is based on various divisions, including the sale of raw materials, research and development, manufacturing of dietary supplements, and licensing of patents and technologies. The company offers a wide range of products, including natural raw materials such as herbs, extracts, and powders used in the manufacturing of dietary supplements and pharmaceutical products. Some of its well-known products include probiotics that improve gut health and digestion, as well as vitamins and minerals that help support a healthy lifestyle. Another division of Integrated Biopharma Inc. is research and development of new products. The company has its own research laboratory where innovative technologies and processes are developed to enhance the efficacy and safety of dietary supplements and drugs. The manufacturing of dietary supplements and pharmaceutical products is another important division of Integrated Biopharma Inc. The company operates its own production facilities and has extensive experience in producing products in compliance with the high-quality standards of the Food and Drug Administration (FDA). In addition to these divisions, Integrated Biopharma Inc. also offers licensing of patents and technologies. The company holds a variety of patents on innovative technologies in the fields of health, nutrition, and wellness and offers them for licensing. The business model of Integrated Biopharma Inc. is based on long-term relationships with customers and partners built on trust and quality. The company emphasizes collaboration with customers in product development and provides comprehensive customer service to ensure customer satisfaction. In summary, the business model of Integrated Biopharma Inc. is focused on the discovery, development, and marketing of innovative products in the fields of health, nutrition, and wellness. The company has divisions including raw materials, research and development, manufacturing of dietary supplements, and licensing of patents and technologies. Integrated Biopharma Inc. values quality and customer relationships and offers comprehensive customer service as well as long-term partnerships with customers and partners.

Hasılat Integrated Biopharma için şu anda hesaplanamaz.

Kar Integrated Biopharma için şu anda hesaplanamaz.

F/K oranı Integrated Biopharma için şu anda hesaplanamaz.

F/S Integrated Biopharma için şu anda hesaplanamaz.

Integrated Biopharma'nin Eulerpool Kalite Puanı 2/10'dur.

Integrated Biopharma'nin ISIN'i US45811V1052'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.

Integrated Biopharma'nin WKN'i 120093'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.

Integrated Biopharma'nin ticker'ı INBP'dir. Ticker sembolü, Integrated Biopharma hisseleri borsada işlem görmek için kullanılır.

Adil DeğerTerminal
0,15 USD
Aşırı-/Eksik DeğerlemeTerminal
Adil Değerlenmiş
Sektör
Kişisel Ürünler
Hisse Sayısı
Çalışan Sayısı
Çalışan Başına Ciro
355.248,37 USD
Gelir Büyümesi Ø5 Yıl
EBIT Büyümesi Ø5 Yıl
Net Kar Büyümesi Ø5 Yıl
Web Sitesi ibiopharma.com
Para Birimi
USD
Halka Arz
30 Eki 1996
ISIN
US45811V1052
CUSIP
45811V105
SEDOL
2408594
Pazar Kapitalizasyonu
5,61 M USDMicro Cap
52 Haftalık Aralık
AAQS
2 / 10
PEG
—
P/E
F/K Oranı
—
P/S
F/S Oranı
—
EV/EBIT
2,78
KBV
0,28
ROCE
ROIC
3,98 %
Son güncelleme 23 Eki 2026 18:14

Integrated Biopharma Ticker

OTC · INBPOTC · INBP

Integrated Biopharma FIGI

INBP:US · BBG000CPQS00INBP:PQ · BBG000CPQZD0INBP:UV · BBG000CPR064